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ABSTRACT
The incidence of a positive family history with asthma 
and levels of serum IgE and IgE antibodies were 
examined in 136 patients with asthma in relation to 
age at onset of the disease. The frequency of subjects 
with a family history of asthma ranged from 37.9 to 
75.0% in all groups classified by age at onset. The 
frequency of patients with a high serum IgE level
(≧150IU/mL)was higher(51.7-63.2%)in all groups
than the frequency of patients with a low serum level 
(< 150 IU/mL). The mean level of serum IgE was 
significantly higher in patients with a family history 
than in those without a family history, in subjects 
between the ages of 50 and 59 years at onset (mean 
age 63.4 years; P<0.02) and in those over the age of 
60 years at onset (74.0 years; P<0.01). The number 
of patients with a positive BAST score either to house 
dust mite (HDM), cockroach, and Candida tended to 
decrease as the age at onset increased. However, the 
frequency of positive BAST to HDM was higher in 
patients with a family history and who were over the
age of 50 years at onset compared with those patients 
between the ages of 40 and 49 years at onset, 
although the frequency was significantly higher in 
patients with family history than in those without family 
history (P<0.02). These results suggest that IgE-
mediated allergic reactions are significant not only in 
those patients who are younger, but also in elderly 
patients with asthma.
Key words: aging, bronchial asthma, family history, 
IgE, inhalant allergen, radioallergosorbent test.
INTRODUCTION
Bronchial asthma is characterized by bronchial 
hyperreactivity to various stimuli in which an IgE-
mediated allergic reaction is considered to be the major 
factor affecting the pathophysiology of the airways. The 
IgE-mediated allergic reaction, which is closely 
associated with the mechanism of onset of asthma, has 
been recognized to change qualitatively and 
quantitatively with age.1-7 Previous studies have shown 
that bronchial reactivity to methacholine and histamine 
release from leukocytes show a tendency to decrease with 
age.8 Thus, asthma in older patients tends to have 
different characteristics from that in younger patients.
 There are two different views regarding the significance 
of IgE-antibodies in the pathogenesis of asthma. One is 
that asthma is clinically classified into two types, atopic 
and non-atopic, on the basis of the presence or absence 
of IgE-mediated reactions,9 where atopic asthma is more 
often found in the younger population and non-atopic 
asthma is found in the older patients. In contrast, there is 
a second concept that asthma is almost always 
associated with some type of IgE-related reaction.10,11 
  In the present study, age-related changes in serum IgE 
levels and the frequency of detection of specific IgE 
antibodies against inhalant allergens were examined. 
The results were analyzed with regard to subjects' family 
history of asthma.
METHODS
The subjects of the present study were 136 patients (73 
females, 63 males; mean age 59.4 years, range 15-90
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years). The mean age at onset was 45.7 years and the 
mean level of serum IgE was 412IU/mL. Of 136 
subjects, 35 (25.7%) had steroid-dependent intractable 
asthma (SDIA), which was estimated by the amount and 
the duration of the systemic steroid required. Patients with 
SDIA comprised 21 females and 14 males (mean age 
62.1 years, range 39-79 years; mean age at onset 47.7 
years; mean level of serum IgE 400IU/mL). Subjects 
were divided into two groups according to their family 
history of asthma. Subjects were also classified into four 
groups according to age at onset: 0-39, 40-49, 50-59 
and 60+ years. Three inhalant allergens, house dust mite
(HDM), cockroach and Candida albicans, were 
estimated by radioallergosorbent test (BAST). The level of 
serum IgE was measured by a radioimmunosorbent test 
(KIST). 
 Statistical analysis was estimated by using the x2 test 
and Student's t-test. A P value of<0.05 was regarded as 
significant.
RESULTS
Table 1 shows patient characteristics classified by age at 
onset of the disease. The mean patient age in the four 
groups ranged from 45.6 to 74.0 years. The mean level 
of serum IgE was high, ranging from 310 to 480 IU/mL. 
The frequency of subjects with a family history of asthma 
ranged from 37.9% in patients over the age of 60 years 
at onset to 75.0% in those patients who were under the 
age of 39 years at onset. Even in patients between the 
ages of 50 and 59 years at onset, 22 of 39 subjects 
(61.1%) had a family history of asthma (Fig. 1). 
 The frequency of patients with a high serum IgE level
(>150IU/mL) was greater (51.7-63.2%) in all groups 
classified by age at onset compared with the frequency of 
subjects with a low serum level (< 150 IU/mL; Fig. 2) and 
in patients over the age of 50 years at onset, the 
frequency of those with a high serum IgE level was 
significantly higher in patients with a family history of 
asthma than in subjects without family history of asthma 
(in subjects between the ages of 50 and 59 years at 
onset, P<0.01; in subjects over the age of 60 years at 
onset, P<0.05; Fig. 3). In contrast, the frequency of 
patients with a low serum IgE level (<150 IU/mL) ranged 
from 37.5 to 47.3% and the frequency increased as the 
age at onset increased (Fig. 2).
 In patients over the age of 50 years at onset, a 
correlation between a family history of asthma and serum 
IgE levels was found: the mean level of serum IgE was
Table 1. Characteristics of patients with asthma studied
Fig. 1 Frequency of asthma patients with a family history of 
allergi  disease and the age at onset.
Fig. 2 Frequency of asthma patients with serum IgE levels
either over 150IU/mL(■)or less than 150 IU/mL(□).
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Fig. 3 Frequency of asthma patien+s with a serum IgE level「
over 150IU/mL and a positive(■)or negotive(□)family
history of allergic diseases.*P<0.01,**P<0.05.
    
Fig. 4 Frequency of asthma patients with positive RAST to
house dust mite(■), cockrooch(□)and Canndid (□)and the
age at onset.
higher in patients with a family history of asthma than in 
subjects without family history and this difference was 
significant in patients between the ages of 50 and 59 
years at onset (P<0.02) and in those over the age of 60 
years at onset (P<0.01; Table 2). 
 Of the 136 subjects, a positive reaction in the BAST 
was observed in 51 (37.5%) for HDM, 20 (14.7%) for 
cockroach and 25 (18.4%) for Candida albicans. The 
frequency of patients with a positive BAST score to HDM 
tended to decrease as the age at onset increased.
Fig. 5 Frequency of asthma patients with positive BAST either 
to house dust mite, cockroach or Candida and age at onset.
Table 2. Serum IgE levels in asthma patients with and without 
a family history of allergic disease
However, even in patients over the age of 60 years at 
onset, 27.6% of subjects showed a positive reaction in 
the BAST to HDM. In contrast, the frequency of positive 
BAST to Candida was 25.0% in patients between the ages 
of 50 a d 59 years at onset (Fig. 4). The positive BAST, 
either to HDM, cockroach or Candida albicans, showed 
 tendency to decrease as the age at onset increased 
(Fig. 5). 
 In patients over the age of 50 years at onset, the 
frequency of positive BAST to HDM was higher in patients 
with a family history of asthma than in subjects without 
family history and the difference was significant in 
patients over the age of 60 years at onset (P<0.02; 
Fig. 6).
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Fig. 6 Frequency of asthma patients with positive BAST to
house dust mite and a positive(■)or negotive (□) family
history of allergic diseases.*P<0.02.
DISCUSSION
In IgE-mediated allergic reactions associated with asthma, 
the release of chemical mediators, such as histamine and 
leukotrienes, occurs in the early stage of an asthma attack 
and inflammatory cell infiltration occurs in the airways at 
the late stage. In the inflammatory process, lympho-
cytes,12,13 neutrophils,14,15 eosinophils16 and basophils17 
have been observed by analyzing the cellular composition 
of bronchoalveolar lavage (BAL) fluid. 
 These humoral and cellular factors in the onset of 
asthma may be affected by aging, which may alter the 
pathophysiology of asthma.8,18-22 For example, for those 
under 30 years of age, a severe asthmatic attack can be
induced by simple bronchoconstriction, while those 
between the ages of 31 and 40 years may be induced by 
bronchospasm and hypersecretion.22,23 The frequency of 
patients with bronchospasm and hypersecretion shows a 
peak between the ages of 51 and 60 years, while the 
number of patients whose clinical findings show 
bronchiolar narrowing increases with age.22 Furthermore, 
bronchial hyperresponsiveness shows a tendency to 
decrease in the elderly.8 
 Immunoglobulin E-mediated allergic reactions are 
also affected by aging.5 Asthma is clinically divided into 
two types: atopic and non-atopic, in relation to the 
presence of IgE-mediated allergic reactions.9 From this 
point of view, it has been suggested that many elderly 
asthmatics are non-atopic. 
 However, it should be noted that pathophysiology in
the airways and IgE-mediated allergic reactions are 
basically different in elderly and in younger patients. 
 In the present study, the significance of an IgE-
mediated allergic reaction in asthma in the elderly was 
estimated by observing serum IgE levels and IgE 
antibodies to inhalant allergens. 
 The frequency of patients with a family history of 
asthma was relatively high, even in patients between the 
ages of 50 and 59 years at onset (mean patient age 63.4
years; 61.1 %) and in those over the age of 60 years at 
onset (mean patient age 74.0 years; 37.9%). The results 
suggest that many elderly asthmatics have an allergic 
constitution. The level of serum IgE and the frequency of 
positive BAST to HDM were higher in these patients with a 
family history of asthma than in those without a family 
history of asthma. The difference in serum IgE levels 
between patients with and without a family history of 
asthma was significant and the difference in positive BAST 
was also significant in patients over the age of 60 years at 
onset. These results demonstrate that many elderly 
asthmatics have a family history of asthma, which is 
closely related to serum IgE levels and positive RAST to 
HDM, indicating the significance of an IgE-mediated 
allergic reaction not only in the young but in elderly 
asthmatics as well.
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